GeneBioTech Co. ,Ltd (KOSDAQ:086060)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,780.00
-35.00 (-0.73%)
At close: Apr 28, 2026
38.95%
Market Cap 40.17B
Revenue (ttm) 90.79B
Net Income (ttm) 3.79B
Shares Out 8.61M
EPS (ttm) 440.00
PE Ratio 10.60
Forward PE n/a
Dividend 50.00 (1.05%)
Ex-Dividend Date Dec 29, 2025
Volume 16,710
Average Volume 31,554
Open 4,815.00
Previous Close 4,815.00
Day's Range 4,755.00 - 4,820.00
52-Week Range 3,340.00 - 5,990.00
Beta 0.53
RSI 33.13
Earnings Date May 15, 2026

About GeneBioTech Co. ,Ltd

GeneBioTech Co. ,Ltd, together with its subsidiaries, engages in the manufacture and sale of feed additives and functional food in South Korea. It also manufactures and sells animal drugs. The company was founded in 2000 and is headquartered in Gongju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2000
Employees 42
Stock Exchange KOSDAQ
Ticker Symbol 086060
Full Company Profile

Financial Performance

In 2025, GeneBioTech Co. ,Ltd's revenue was 90.79 billion, an increase of 9.44% compared to the previous year's 82.96 billion. Earnings were 3.79 billion, an increase of 32.23%.

Financial Statements

News

There is no news available yet.